Canada markets closed

Deciphera Pharmaceuticals, Inc. (DCPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
25.380.00 (0.00%)
At close: 04:00PM EDT
25.31 -0.07 (-0.28%)
After hours: 05:46PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-194,942
-194,942
-178,931
-299,964
-266,489
Depreciation & amortization
2,100
2,100
2,946
3,014
2,305
Stock based compensation
50,603
50,603
51,942
46,078
37,137
Change in working capital
-1,536
-1,536
-31,648
820
-13,852
Accounts receivable
-9,345
-9,345
-1,784
-6,699
-13,896
Inventory
-386
-386
-7,109
-10,155
-3,241
Accounts Payable
7,777
7,777
5,319
833
-7,533
Other working capital
-147,475
-147,475
-153,703
-246,794
-244,999
Other non-cash items
4,475
4,475
4,126
7,446
2,834
Net cash provided by operating activites
-146,697
-146,697
-152,862
-240,824
-239,683
Cash flows from investing activities
Investments in property, plant and equipment
-778
-778
-841
-5,970
-5,316
Purchases of investments
-322,572
-322,572
-322,767
-335,375
-1,096,769
Sales/Maturities of investments
335,899
335,899
289,299
518,200
1,132,129
Other investing activites
-
-
-
-7
-1,592
Net cash used for investing activites
12,549
12,549
-34,309
176,848
28,459
Cash flows from financing activities
Debt repayment
-
-
-
0
0
Common stock issued
149,747
149,747
163,778
8,589
207,231
Other financing activites
-634
-634
-425
-40
-815
Net cash used privided by (used for) financing activities
152,004
152,004
164,994
14,890
226,801
Net change in cash
17,856
17,856
-22,177
-49,086
15,577
Cash at beginning of period
64,741
64,741
87,063
135,897
120,320
Cash at end of period
83,507
83,507
64,741
87,063
135,897
Free Cash Flow
Operating Cash Flow
-146,697
-146,697
-152,862
-240,824
-239,683
Capital Expenditure
-778
-778
-841
-5,970
-5,316
Free Cash Flow
-147,475
-147,475
-153,703
-246,794
-244,999